Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2023-02-23 00:00:00 ET · period of report 2023-02-22 · accession 0001567619-23-003701 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-23 | 2023-02-22 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.49 | +45.0K | 251.9K | +22% | +$22.1K |
| D | 2023-02-23 | 2023-02-22 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.00 | -45.0K | 102.4K | -31% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-22 | M | A | 45,000 | $0.49 | 251,872 | D | — | — | (F1) Includes 111,500 restricted stock units. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-02-22 | M | D | 45,000 | $0.00 | 102,446 | D | $0.49 · 2020-12-01 to 2027-03-20 | 45,000 Common Stock |